These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 7660911)

  • 1. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
    Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
    Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.
    Terasaka T; Nakanishi I; Nakamura K; Eikyu Y; Kinoshita T; Nishio N; Sato A; Kuno M; Seki N; Sakane K
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1115-8. PubMed ID: 12643924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition.
    Manthei SA; Reiling CM; Van Wylen DG
    Cardiovasc Res; 1998 Jan; 37(1):171-8. PubMed ID: 9539871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart.
    Sandhu GS; Burrier AC; Janero DR
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1249-56. PubMed ID: 8238412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.
    Abd-Elfattah AS; Maddox RP; Jessen ME; Rebeyka IM; Wechsler AS
    Mol Cell Biochem; 1998 Mar; 180(1-2):145-51. PubMed ID: 9546641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does adenosine deaminase inhibition protect ischemic myocardium?
    Gallagher KP; McClanahan TB; Martin BJ; Saganek LJ; Ignasiak DP; Mertz TE; Van Wylen DG; Vinten-Johansen J
    Adv Exp Med Biol; 1994; 370():291-4. PubMed ID: 7660911
    [No Abstract]   [Full Text] [Related]  

  • 7. Can adenosine deaminase inhibitors be cytoprotective agents?
    Barankiewicz J; Danks AM; Marangos PJ
    Adv Exp Med Biol; 1998; 431():395-9. PubMed ID: 9598099
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of possible relation of defects in purine metabolism to immune deficiency.
    Seegmiller JE
    Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
    [No Abstract]   [Full Text] [Related]  

  • 10. Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia.
    Kane BJ; Kuhn JG; Roush MK
    Ann Pharmacother; 1992; 26(7-8):939-47. PubMed ID: 1504408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzyme inhibitors as drugs. I].
    Nuhn P
    Pharm Unserer Zeit; 1997 May; 26(3):127-42. PubMed ID: 9304117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme inhibitors as drugs. III].
    Nuhn P
    Pharm Unserer Zeit; 1998 Jan; 27(1):12-7. PubMed ID: 9562779
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.